Navamedic ASA (OSL:NAVA)
21.70
-0.50 (-2.25%)
May 13, 2025, 4:17 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Precription Drugs | 300.30M |
Log In |
Log In |
Log In |
Log In |
Consumer Health | 108.87M |
Log In |
Log In |
Log In |
Log In |
Consumer Health Growth | 36.74% |
Log In |
Log In |
Log In |
Log In |
Hospital | 102.82M |
Log In |
Log In |
Log In |
Log In |
Specialty Pharma | - |
Log In |
Log In |
Log In |
Log In |
Specialty Pharma Growth | - |
Log In |
Log In |
Log In |
Log In |
Branded Generics | - |
Log In |
Log In |
Log In |
Log In |
Branded Generics Growth | - |
Log In |
Log In |
Log In |
Log In |
Medical Nutrition | - |
Log In |
Log In |
Log In |
Log In |
Medical Nutrition Growth | - |
Log In |
Log In |
Log In |
Log In |
Other | - |
Log In |
Log In |
Log In |
Log In |
Other Growth | - |
Log In |
Log In |
Log In |
Log In |
Medtech | - |
Log In |
Log In |
Log In |
Log In |
Medtech Growth | - |
Log In |
Log In |
Log In |
Log In |
Discontinued Operations | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Norway | 214.12M |
Log In |
Log In |
Log In |
Log In |
Norway Growth | 7.66% |
Log In |
Log In |
Log In |
Log In |
Sweden | 158.92M |
Log In |
Log In |
Log In |
Log In |
Sweden Growth | 64.27% |
Log In |
Log In |
Log In |
Log In |
Netherlands | 54.01M |
Log In |
Log In |
Log In |
Log In |
Denmark | 38.07M |
Log In |
Log In |
Log In |
Log In |
Denmark Growth | 35.25% |
Log In |
Log In |
Log In |
Log In |
Finland | 27.71M |
Log In |
Log In |
Log In |
Log In |
Finland Growth | 54.35% |
Log In |
Log In |
Log In |
Log In |
Other Countries | 19.18M |
Log In |
Log In |
Log In |
Log In |
Other Countries Growth | -52.54% |
Log In |
Log In |
Log In |
Log In |